In the wake of last week’s publicity around Bob Jöndell become the CFO for a life science company want to Enzymatica announce that Bengt remains as t f CFO at half-time for Enzymatica until a new CFO has been recruited.
For more information, please contact:
Fredrik Lindberg, CEO Enzymatica AB
Tel: 0708-86 53 70 | E-mail: fredrik.lindberg@enzymatica.com
About Enzymatica AB
Enzymatica AB is a medical technology company that develops and sells medical products against infektionsrelaterade diseases. In a short time, the company has developed ColdZyme®, a unique oral spray for cold, launched the product in eight markets, and established themselves among the best-selling förkylningsprodukterna, calculated in Swedish kronor on the Swedish pharmacy. The strategy is to continue to grow by strengthening its position in existing markets and expand into more geographic markets via the established partners. The company has headquarters in Lund, sweden and is listed on Nasdaq First North. For more information, please visit: www.enzymatica.se.
Enzymaticas Certified Adviser is Erik Penser Bank.
Press release (PDF)
